tiprankstipranks
Rapt Therapeutics downgraded to Underweight from Neutral at JPMorgan
The Fly

Rapt Therapeutics downgraded to Underweight from Neutral at JPMorgan

JPMorgan downgraded Rapt Therapeutics (RAPT) to Underweight from Neutral.

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App